Public comment submission to FDA docket FDA-2026-D-1256 — Considerations for the Use of the Plausible Mechanism Framework To Develop Individualized Therapies That Target Specific Genetic Conditions With Known Biological Cause (CBER + CDER joint draft guidance, FR 2026-03713, released 2026-02-25; comment deadline 2026-04-27 23:59 ET).
Status (2026-04-25) — Submitted to regulations.gov. Interim tracking:
mod-xns0-69oq. Final docket comment ID will be assigned by FDA when the comment is posted. The bundle in this repository is byte-frozen at the submitted version; per-file SHA-256 hashes are inbundle/expected_sha256.txtand verifiable viabundle/script/verify.sh.
⚠️ DISCLAIMER — Methodological exploration. Not for clinical, regulatory, commercial, or personal-use purposes. The comment proposes structured-record formats for plausible-mechanism evidence; it does not endorse, apply for, or recommend any specific therapy.
Sibling repository to FDA-2026-D-1255 (NGS off-target methodology; in preparation, deadline 2026-07-14). The two dockets are methodologically complementary:
| D-1255 | D-1256 | |
|---|---|---|
| Layer | Methodology (NGS off-target execution) | Framework (what evidence counts as plausible) |
| Sponsor duty | Run per-methodology off-target analysis | Assemble plausible-mechanism evidence package |
| Record role | Parameter library for variant-aware pipeline | Reasoning manifest schema for mechanism → outcome |
- Attachment 1 —
bundle/docket_comment.pdf— the full comment (§1–§10, Appendix A–D). - Attachment 2 — schema bundle (zip): the schema (
bundle/d1256_schema_v0.1.json, Draft 0.2), two worked instances (BCL11A, AAVS1), their validator renders, the reference validator, and a 36-test pytest suite. - Attachment 3 —
bundle/expected_sha256.txt— SHA-256 manifest of deterministic outputs.
# Verify all deterministic outputs match the SHA-256 manifest
bash bundle/script/verify.sh
# Expected: ok=8 mismatch=0 missing=0
# Run the validator against the bundled instances
python3 scripts/d1256_validate_and_render.py bundle/d1256_schema_instance_BCL11A.json
python3 scripts/d1256_validate_and_render.py bundle/d1256_schema_instance_AAVS1.json
# Expected: "OK (schema Draft 2020-12 validation passed)."
# Run the regression test suite
pytest scripts/test_d1256_validator.py -q
# Expected: 36 passedbundle/
├── docket_comment.{md,html,pdf} Final comment text (18 pp PDF)
├── d1256_schema_v0.1.json JSON Schema 2020-12, Draft 0.2
├── d1256_schema_instance_BCL11A.json Worked example: BCL11A +58 enhancer
├── d1256_schema_instance_AAVS1.json Worked example: AAVS1 safe-harbor
├── renders/ Validator-generated human-readable renders
├── citations.bib Bibliography
├── expected_sha256.txt Reproducibility manifest
└── script/ verify.sh, make_pdf.sh
scripts/
├── d1256_validate_and_render.py Reference validator + Markdown renderer
└── test_d1256_validator.py pytest suite (36 tests)
submission_log.md Append-only submission tracking
- Code (
scripts/,bundle/script/): Apache 2.0 - Documentation and specifications (
bundle/docket_comment.*, this README): CC-BY 4.0 - Schema and manifest instances (
bundle/d1256_schema_v0.1.json,bundle/d1256_schema_instance_*.json,bundle/renders/*.md): CC0
See LICENSE for details.
FDA-2026-D-1255 — the methodology-layer companion (NGS off-target safety assessment for Cas9-based human somatic genome editing; in preparation, deadline 2026-07-14).
Charles Jia (robotmem project) — gadesawnordeatine@gmail.com
Jia, C. (2026). Public comment on FDA-2026-D-1256: a structured reasoning manifest for plausible-mechanism evidence packages. Docket comment. https://github.com/robotmem/fda-comment-FDA-2026-D-1256